Innofactor’s Q2 results were as expected. Net sales amounted to EUR 17.
No surprises in Q2 SRV reported Q2 results that were fairly well in line with expectations.
Recurring PTP of SEK 70m, 8% above ABGSCe Rental income was SEK 160m in Q2, in line with ABGSCe.
2’21 marked by lower activity, electricity income and winds Arise delivered a weak Q2 report, with s...
Redeye will likely increase its forecasts and Base case slightly, following a Q2 report showing a solid rebound in line with our expectation...
Redeye comments on Safeture's Q2'21 report, which was stable sales and ARR-wise, although slightly b...
Redeye raises its forecasts and Base case for ZetaDisplay following a solid Q2 report showing a mark...
Guidance upgraded pre-Q2 after solid quarter Vaisala reports its Q2 results on July 23rd.
While Q2 was slightly below our estimates, focus is on the Indra order for three satellites, a demon...
Redeye provides an extended research note to discuss the top line deviation, PrivX momentum, and imp...
Q2 margins declined pretty much as expected Sales mix (tilt to carbon fibers) as well as volumes continued to improve and Q2 top line grew b...
Redeye comments on Evolution’s report of the second quarter of 2021.
SRV's net sales in Q2 amounted to EUR 218.0m, below our and consensus estimates (EUR 232.
Atria's strong Q2 results included adjusted EBIT of EUR 12.
Arbitration proceedings outcome to burden Q2 results Consti will report its Q2 results on July 23rd.
Q2 results beat extremely challenging comps Nordic Waterproofing (NWG) continues to beat expectation...
EBITDA likely up q-o-q on higher volumes and prices We estimate Q2’21 EBITDA of SEK 88m, up from SEK 65m in Q1’21.
Q2 results Sales SEK 2,786m (-2% vs ABGSCe 2,850m, -3% vs.
Early signs of recovery for struggling cold remedy market Cold markets continue to be impacted by the pandemic, with increased hand hygiene ...
Operations continue to improve Pricer continues to benefit from its strong position in the rapidly g...
Safeture’s Q2 report was solid, with the ARR growing by 66% y/y and net sales by 39% y/y.
Stark återhämtning i Q2... Midway rapporterade organisk tillväxt på 43% och försäljningen var 18% bättre än EPBs förväntningar.
Redeye views the Q2 from Cellavision this morning as very much in line with our expectations and con...
Mycket stark Q1... Lagercrantz rapporterade organisk tillväxt på imponerande 18% med förvärv som bid...
Slår våra förväntningar Omsättningen i Q2 uppgick till 108,7 mkr jämfört med våra estimat om 101,4 mkr.
Exel Composites’ Q2 report was throughout better than we expected.
Q2 results Sales SEK 389m (0.9% vs ABGSC 386m), Gross profit SEK 95m (1.
